Keyword Tag Sort by

Gastric cancer News (11 articles)



Autoimmune Diseases Affect Cancer Risk

In a recently published study, scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have calculated the interrelations between autoimmune diseases and cancer of the digestive tract. They discovered that many autoimmune diseases increase the cancer risk,...

Published on 11 October 2011, 09:47


Study explains why men are at higher risk for stomach cancer

MIT researchers show how estrogen protects women from the gastric inflammation that can lead to cancer.CAMBRIDGE, Mass. - Several types of cancer, including stomach, liver and colon, are far more common in men than in women. Some scientists have theorized that differences in lifestyle, such as...

Published on 13 July 2011, 16:22


Perceived Health Can Predict Survival of Esophago-Gastric Cancer

Changes in patients' self-rated quality of life after treatment for esophago-gastric cancer can predict the chances for long-term survival. This is the result researchers at the Swedish medical university Karolinska Institutet made, in a new study published in the Journal of Clinical...

Published on 9 March 2010, 03:04


Gene regulation: Can we stomach it?

Max Planck scientists succeed with a novel technique in the fight against the cause of peptic ulcer disease and gastric cancer.A breakthrough in decoding gene regulation of Helicobacter pylori has been made by an international research team led by Jörg Vogel of the Max Planck Institute for...

Published on 23 February 2010, 05:28


Herceptin Now Approved in the EU for Patients With HER2-Positive Advanced Stomach Cancer

First targeted biological therapy to show survival benefit in stomach cancer.Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Herceptin (trastuzumab) in combination with chemotherapy for use in patients with HER2-positive metastatic stomach (gastric)...

Published on 28 January 2010, 05:03


Team finds link between stomach-cancer bug and cancer-promoting factor

CHAMPAIGN, lll. — Researchers report that Helicobacter pylori, the only bacterium known to survive in the harsh environment of the human stomach, directly activates an enzyme in host cells that has been associated with several types of cancer, including gastric cancer.Chronic infection with H....

Published on 6 January 2010, 10:29


Team finds link between stomach-cancer bug and cancer-promoting factor

CHAMPAIGN, lll. — Researchers report that Helicobacter pylori, the only bacterium known to survive in the harsh environment of the human stomach, directly activates an enzyme in host cells that has been associated with several types of cancer, including gastric cancer.Chronic infection with H....

Published on 6 January 2010, 10:29


Duke/Singapore Scientists Find New Way to Classify Gastric Cancers

An international team of scientists has discovered a new way to classify stomach cancers, and researchers say it may be an important step toward designing more effective treatments and improving long-term survival.Stomach (gastric) cancer is particularly prevalent in Asia and represents the...

Published on 2 October 2009, 04:24


Herceptin provides impressive survival benefit for patients with high levels of HER2 in their stomach cancer

Herceptin filed in Europe for treatment in HER2-positive advanced gastric cancer based on ToGA study results.A detailed analysis of the Phase III ToGA study announced today revealed an unprecedented survival benefit for patients whose tumours exhibited a particularly high level of HER2 when...

Published on 24 September 2009, 07:19


New Minimally Invasive Surgery Option for Patients with Stomach Cancer

NEW YORK, NY - A novel, minimally invasive surgical approach to treat stomach cancer has been shown to have advantages that may make it a preferable treatment for some patients.A new study led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) compares traditional "open"...

Published on 15 April 2009, 15:06


Afinitor® Phase II trial results positive in patients with advanced gastric cancer after failure of one or more prior treatments

After eight weeks of treatment Afinitor halted tumor growth in 55% of advanced gastric cancer patients previously treated with chemotherapy   Based on these promising data, Novartis will initiate a Phase III trial of Afinitor for advanced gastric cancer patients  Gastric...

Published on 14 January 2009, 04:35


image